Digital Health Technology is Taking Off Off in Clinical Trials
In a new survey (of 166 biopharma and life sciences industry researchers, executives and technology/software professionals) on how digital health devices and data impact clinical trials, digital health technology vendor Validic reported:
- Sixty percent of respondents said they have used digital health technology to conduct clinical trials.
- Ninety-seven percent of respondents said they will increase their use of digital technologies in clinical trials in the next five years.
- Mobile apps and in-home clinical-grade devices are currently the most commonly used devices in clinical drug trials, but wearable activity trackers and sensors will be the focus of future use.
- Seventy percent of respondents said patient-generated health data (PGHD) could have the greatest impact on improving treatments for chronically ill populations.
Further Reading:
- “GSK and MIT Team Up to Test Flumoji - an Android App That May Provide RWE in Clinical Trials”; http://sco.lt/5UBpM9
- “Review: The Use of Social Media in Recruitment for Medical Research Studies”; http://sco.lt/6L6KQL
- “How Novartis is transforming clinical trials with social media”; http://sco.lt/7CN4yn
- “How to Get 11,000 Clinical Trial Participants Signed Up in One Day!”; http://sco.lt/8kh7Cr
Reactions
(26)
No comment yet.
Sign up to comment